ORBIMED ADVISORS LLC Insider Trading $VRAY ViewRay, Inc.
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
ORBIMED ADVISORS LLC in ViewRay, Inc.
Trading Symbol: VRAYIndustry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 7,464,378 shares
Current Value: $44,413,049
Latest Transaction: Aug 20 2018
$VRAY Market Capitalization: $257.35M
$VRAY Previous Close: $5.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in ViewRay, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 1,466 | 14,631 | 69,617 | 71.1 K to 69.6 K (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 153,921 | 1,536,132 | 7,310,457 | 7.5 M to 7.3 M (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 3,455 | 34,343 | 71,083 | 74.5 K to 71.1 K (-4.64 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 362,765 | 3,605,884 | 7,464,378 | 7.8 M to 7.5 M (-4.63 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 736 | 7,308 | 74,538 | 75.3 K to 74.5 K (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 77,314 | 767,728 | 7,827,143 | 7.9 M to 7.8 M (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 198 | 1,968 | 75,274 | 75.5 K to 75.3 K (-0.26 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 20,777 | 206,523 | 7,904,457 | 7.9 M to 7.9 M (-0.26 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 820 | 8,184 | 75,472 | 76.3 K to 75.5 K (-1.07 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 86,103 | 859,308 | 7,925,234 | 8 M to 7.9 M (-1.07 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 249 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 26,139 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 431 | 3,457 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 45,203 | 362,528 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 184 | 920 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 19,372 | 96,860 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 6,460 | 64,342 | 75,573 | 82 K to 75.6 K (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 678,333 | 6,756,197 | 7,935,856 | 8.6 M to 7.9 M (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 249 | 2,455 | 82,033 | 82.3 K to 82 K (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 26,139 | 257,731 | 8,614,189 | 8.6 M to 8.6 M (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 615 | 6,095 | 82,282 | 82.9 K to 82.3 K (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 64,575 | 639,938 | 8,640,328 | 8.7 M to 8.6 M (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 431 | 2,155 | 82,897 | 82.5 K to 82.9 K (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 45,203 | 226,015 | 8,704,903 | 8.7 M to 8.7 M (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 184 | 920 | 82,466 | 82.3 K to 82.5 K (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 19,372 | 96,860 | 8,659,700 | 8.6 M to 8.7 M (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 1,036 | 10,308 | 82,282 | 83.3 K to 82.3 K (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 108,729 | 1,081,854 | 8,640,328 | 8.7 M to 8.6 M (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 4,553 | 45,530 | 83,318 | 87.9 K to 83.3 K (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 478,107 | 4,781,070 | 8,749,057 | 9.2 M to 8.7 M (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 249 | 0 | 87,871 | 87.6 K to 87.9 K (+0.28 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 26,139 | 0 | 9,227,164 | 9.2 M to 9.2 M (+0.28 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 249 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 0.00 | 26,139 | 0 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 431 | 3,457 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 8.02 | 45,203 | 362,528 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 184 | 920 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.00 | 19,372 | 96,860 | 0 | |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 6,460 | 64,342 | 75,573 | 82 K to 75.6 K (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.96 | 678,333 | 6,756,197 | 7,935,856 | 8.6 M to 7.9 M (-7.87 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 249 | 2,455 | 82,033 | 82.3 K to 82 K (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.86 | 26,139 | 257,731 | 8,614,189 | 8.6 M to 8.6 M (-0.30 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 615 | 6,095 | 82,282 | 82.9 K to 82.3 K (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.91 | 64,575 | 639,938 | 8,640,328 | 8.7 M to 8.6 M (-0.74 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 431 | 2,155 | 82,897 | 82.5 K to 82.9 K (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 45,203 | 226,015 | 8,704,903 | 8.7 M to 8.7 M (+0.52 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 184 | 920 | 82,466 | 82.3 K to 82.5 K (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.00 | 19,372 | 96,860 | 8,659,700 | 8.6 M to 8.7 M (+0.22 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 1,036 | 10,308 | 82,282 | 83.3 K to 82.3 K (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.95 | 108,729 | 1,081,854 | 8,640,328 | 8.7 M to 8.6 M (-1.24 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 4,553 | 45,530 | 83,318 | 87.9 K to 83.3 K (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.00 | 478,107 | 4,781,070 | 8,749,057 | 9.2 M to 8.7 M (-5.18 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 249 | 0 | 87,871 | 87.6 K to 87.9 K (+0.28 %) |
Aug 10 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 0.00 | 26,139 | 0 | 9,227,164 | 9.2 M to 9.2 M (+0.28 %) |
Aug 07 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.01 | 478 | 4,785 | 87,622 | 88.1 K to 87.6 K (-0.54 %) |
Aug 07 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.01 | 50,149 | 501,991 | 9,201,025 | 9.3 M to 9.2 M (-0.54 %) |
Aug 07 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.71 | 1,125 | 13,174 | 88,100 | 89.2 K to 88.1 K (-1.26 %) |
Aug 07 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.71 | 118,168 | 1,383,747 | 9,251,174 | 9.4 M to 9.3 M (-1.26 %) |
Jan 20 2017 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 3.17 | 623 | 1,975 | 3,843 | |
Jan 20 2017 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 3.17 | 65,491 | 207,606 | 403,692 | |
Jan 20 2017 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 3.00 | 3,118 | 9,354 | 89,225 | 86.1 K to 89.2 K (+3.62 %) |
Jan 20 2017 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 3.00 | 327,459 | 982,377 | 9,369,342 | 9 M to 9.4 M (+3.62 %) |
Aug 24 2016 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 2.95 | 3,220 | 9,499 | 3,220 | |
Aug 24 2016 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 2.95 | 338,201 | 997,693 | 338,201 | |
Aug 24 2016 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 2.95 | 10,736 | 31,671 | 86,107 | 75.4 K to 86.1 K (+14.24 %) |
Aug 24 2016 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 2.95 | 1,127,338 | 3,325,647 | 9,041,883 | 7.9 M to 9 M (+14.24 %) |
Page: 1